USC.edu
Are You a Patient?

Daniel J. Fernandez

Postdoctoral Scholar - Fellowship Trainee

Image of Daniel J. Fernandez
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers. Cancer Res. 2026 Sep 14.. View in PubMed
  • Tear Proteomics Reveals RAGE and NLRP3 Inflammasome Pathway Activation in Lacrimal Glands of a Sjögren’s Disease Mouse Model. bioRxiv. 2026 Jul 20.. View in PubMed
  • Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive Cancer. Cancers (Basel). 2026 Feb 12; 18(4).. View in PubMed
  • NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability. bioRxiv. 2025 Sep 26.. View in PubMed
  • HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages. J Immunother Cancer. 2025 Aug 19; 13(8).. View in PubMed
  • Human Papillomavirus Type 16 Stimulates WAVE1- and WAVE2-Dependent Actin Protrusions for Endocytic Entry. Viruses. 2025 04 08; 17(4).. View in PubMed
  • MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation. Epigenetics Chromatin. 2021 05 17; 14(1):23.. View in PubMed
  • Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering. Front Immunol. 2020; 11:561843.. View in PubMed
  • TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy. Front Immunol. 2020; 11:922.. View in PubMed
  • Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation. Sci Rep. 2018 08 03; 8(1):11642.. View in PubMed

Similar People